Edwards Lifesciences Corporation (EW) is in Healthcare, Medical Devices, based in United States, listed on NYSE. Market cap 48.51B USD. 52-week range 72.30 to 96.29 USD. Trailing P/E 50.1. Data as of 2026-10-09.
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also ...